Parand Darou News

Milan, Italy – Pharmex 2026 During Pharmex 2026, Mr. Yahya Mirzaei, CEO of Parand Darou Pharmaceutical Company, discussed the importance of industrial resilience, continuity of pharmaceutical production, energy challenges, export development, and the strategic role of active pharmaceutical ingredients (APIs) in ensuring healthcare security. Mr. Mirzaei emphasized that pharmaceutical security cannot be achieved during a crisis and must be built before challenging situations emerge. According to him, ensuring medicine availability depends...

Parand Darou Awarded "National Exemplary Exporter" Title for the Second Time According to the Public Relations department of Parand Darou Pharmaceutical Company, during the 29th National Export Day commemoration ceremony held today in the presence of the President of the Islamic Republic of Iran, Parand Darou once again demonstrated its excellence by securing the prestigious title of "National Exemplary Exporter" and receiving the Golden Export Statue for the second time. In...

Dr. Yahya Mirzaei Appointed as the New CEO of Parand Darou In an official appointment, Mr. Behzad Mohammadi, CEO of Kimiya Group, has appointed Dr. Yahya Mirzaei as the new CEO of Parand Darou. Dr. Mirzaei holds a Ph.D. in Organic Chemistry and an MBA with a specialization in Strategic Management. He brings over 23 years of senior management experience in the pharmaceutical industry and nearly a decade of academic teaching...

Parand Darou Named National Exemplary Exporter of 2024: A Milestone in Pharmaceutical Innovation On Sunday, October 20, 2024, coinciding with National Export Day, Parand Darou Pharmaceutical Company was honored at the Summit Hall in Tehran. In a ceremony attended by the President of the Islamic Republic of Iran and the Minister of Industry, Mine and Trade, Parand Darou was awarded the Certificate of Merit and the Golden Statue as the...

Prominent Presence of Iran at Pharmtech 2024 Russia: Showcasing Iranian API Capabilities The Pharmtech 2024 International Exhibition in Russia, one of the largest specialized events in the pharmaceutical industry, hosted the booth of the Kimiya Group companies (Kimiyagaran Emrooz and Parand Darou) as representatives of Iranian Active Pharmaceutical Ingredient (API) manufacturers. These two companies actively participated in the event with the aim of showcasing their technical and production capabilities and...